PetIQ (NASDAQ:PETQ) Upgraded to Buy at BidaskClub

BidaskClub upgraded shares of PetIQ (NASDAQ:PETQ) from a hold rating to a buy rating in a research note issued to investors on Friday morning, BidAskClub reports.

Other research analysts have also issued research reports about the company. SunTrust Banks boosted their target price on PetIQ from $30.00 to $35.00 and gave the company a buy rating in a research report on Friday, May 8th. Guggenheim boosted their price target on PetIQ from $33.50 to $44.00 and gave the company a buy rating in a report on Thursday, June 25th. They noted that the move was a valuation call. Oppenheimer reiterated a buy rating on shares of PetIQ in a report on Friday, May 8th. Zacks Investment Research lowered PetIQ from a buy rating to a hold rating in a report on Tuesday, May 12th. Finally, Raymond James boosted their price target on PetIQ from $32.00 to $35.00 and gave the company an outperform rating in a report on Tuesday, June 16th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. PetIQ currently has an average rating of Buy and an average target price of $36.50.

Shares of NASDAQ:PETQ opened at $33.86 on Friday. PetIQ has a 1 year low of $15.83 and a 1 year high of $36.33. The business has a 50 day simple moving average of $29.88 and a two-hundred day simple moving average of $27.52. The firm has a market capitalization of $971.73 million, a PE ratio of -52.09, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. The company has a debt-to-equity ratio of 1.04, a current ratio of 2.85 and a quick ratio of 1.67.

PetIQ (NASDAQ:PETQ) last announced its earnings results on Thursday, May 7th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.17 by $0.02. PetIQ had a positive return on equity of 8.28% and a negative net margin of 2.03%. The business had revenue of $186.78 million during the quarter, compared to analyst estimates of $176.52 million. Equities research analysts expect that PetIQ will post 1.06 EPS for the current fiscal year.

In other PetIQ news, Director Will Santana sold 17,500 shares of the company’s stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $31.43, for a total transaction of $550,025.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders have sold 76,667 shares of company stock valued at $2,388,649. 24.12% of the stock is owned by company insiders.

Institutional investors have recently bought and sold shares of the business. Great West Life Assurance Co. Can purchased a new stake in PetIQ during the fourth quarter worth $31,000. Toth Financial Advisory Corp purchased a new stake in PetIQ during the first quarter worth $40,000. Banque Cantonale Vaudoise purchased a new stake in PetIQ during the fourth quarter worth $82,000. Advisor Group Inc. lifted its holdings in PetIQ by 8.6% during the fourth quarter. Advisor Group Inc. now owns 5,105 shares of the company’s stock worth $128,000 after buying an additional 405 shares during the period. Finally, Citigroup Inc. lifted its holdings in PetIQ by 155.7% during the fourth quarter. Citigroup Inc. now owns 5,917 shares of the company’s stock worth $148,000 after buying an additional 3,603 shares during the period. Institutional investors own 94.75% of the company’s stock.

PetIQ Company Profile

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

Further Reading: FinTech

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.